[Therapeutic considerations in chronic myeloid leukemia].
D002066:Busulfan / Q000009:adverse effects / Q000627:therapeutic use; D002908:Chronic Disease; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D006842:Hydrocarbons, Brominated / Q000009:adverse effects / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000175:diagnosis / Q000532:radiotherapy / Q000628:therapy*; D008353:Mannitol / Q000009:adverse effects / Q000627:therapeutic use
D006842:Hydrocarbons, Brominated; D003561:Cytarabine; D008353:Mannitol; D002066:Busulfan
Therapeutische Uberlegungen bei der chronischen myeloischen Leukämie.